Salarius PharmaceuticalsSLRX
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
01/01 08:00 (UTC+8)
Salarius PharmaceuticalsSLRX
0
0
(0%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 895 | 965 | - | - | - | - | 1,772 | 971 | 2,532 | 3,972 |
研發費用 | 62 | 116 | 76 | 175 | 137 | 214 | 243 | 60 | 1,036 | 2,352 |
推銷及管理費用 | 833 | 849 | 1,643 | 1,313 | 869 | 1,253 | 1,529 | 911 | 1,496 | 1,620 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -895 | -966 | -1,719 | -1,489 | -1,006 | -1,468 | -1,772 | -971 | -2,532 | -3,971 |
其他收入及費用 | 22 | 8 | 9 | 25 | 34 | 43 | 56 | 89 | 89 | 94 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -873 | -958 | -1,710 | -1,464 | -972 | -1,424 | -1,715 | -882 | -2,443 | -3,877 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -873 | -958 | -1,710 | -1,464 | -972 | -1,424 | -1,715 | -882 | -2,443 | -3,877 |
基本每股稅後盈餘(元) | -1.81 | -0.45 | -1.03 | -2.25 | -0.76 | -2.37 | -0.41 | - | -0.65 | -1.43 |
稀釋每股稅後盈餘(元) | 6.80 | -0.38 | -1.03 | -0.66 | 0.49 | -2.35 | -0.41 | 0.00 | -0.39 | -1.22 |
基本平均股數(千股) | 481.00 | 2122.00 | 1663.00 | 1443.00 | 1281.00 | 600.00 | 4194.00 | - | 3754.00 | 2709.00 |
稀釋平均股數(千股) | 481.00 | 2122.00 | 1663.00 | 1443.00 | 1281.00 | 600.00 | 4194.00 | - | 3754.00 | 2709.00 |
還原基本每股稅後盈餘(元) | -1.81 | -6.75 | -15.45 | -33.77 | -11.38 | -35.55 | -49.05 | - | -78.15 | -171.75 |
還原稀釋每股稅後盈餘(元) | 6.80 | -5.70 | -15.45 | -9.89 | 7.34 | -35.25 | -49.05 | -0.45 | -46.50 | -146.54 |
還原基本平均股數(千股) | 481 | 141 | 110 | 96 | 85 | 40 | 34 | - | 31 | 22 |
還原稀釋平均股數(千股) | 481 | 141 | 110 | 96 | 85 | 40 | 34 | - | 31 | 22 |
EBITDA(千元) | -872 | -957 | -1,709 | -1,463 | -971 | -1,423 | -1,714 | -881 | -2,437 | -3,875 |